News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Novartis to Acquire Tourmaline Bio, Strengthening Cardiovascular Pipeline with Pacibekitug for Atherosclerotic Cardiovascular Disease (ASCVD)
Tuesday, September 09, 2025Novartis has announced an agreement to acquire Tourmaline Bio Inc Nasdaq TRML a New Yorkbased clinicalstage biopharmaceutical company developing pacibekitug an antiIL monoclonal antibody mAb
BioNTech Expands Manufacturing Capabilities in Europe
Monday, September 08, 2025
Novo Nordisk and GSK Collaborate on Obesity Drug Development
Monday, September 08, 2025
Biopharma Partnership Formed for Development of Innovative mRNA-Based Therapies
Sunday, September 07, 2025
European Medicines Agency Approves New Guidelines for Clinical Trials in Pediatric Populations
Sunday, September 07, 2025
New Manufacturing Facility Opens in Germany for mRNA Production
Saturday, September 06, 2025
European Pharma Companies Collaborate to Advance Gene Therapies
Saturday, September 06, 2025
New Digital Health Regulations to Foster Innovation in Clinical Trials Across Europe
Friday, September 05, 2025
European Biopharmaceutical Industry Sees 15% Growth Amidst Strategic Collaborations
Friday, September 05, 2025
Argo Biopharma signs multi-asset licence and option agreements with Novartis for cardiovascular disease treatments
Friday, September 05, 2025Argo Biopharmaceutical Co Ltd Argo Biopharma a clinicalstage biotechnology company developing nextgeneration siRNA medicines has entered into new agreements with Novartis for several cardiovascular
